-
1
-
-
0027971263
-
Activity of KRM-1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection
-
BERMUDEZ, L. E., KOLONOSKI, P., YOUNG, L. S., and INDERLIED, C. B., 1994, Activity of KRM-1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. Antimicrobial Agents and Chemotherapy, 38, 1844-1848.
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, pp. 1844-1848
-
-
Bermudez, L.E.1
Kolonoski, P.2
Young, L.S.3
Inderlied, C.B.4
-
2
-
-
0027537219
-
Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits
-
EMORI, M., SAITO, H., SATO, K., TOMIOKA, H., SETOGAWA, T., and HIDAKA, T., 1993, Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. Antimicrobial Agents and Chemotherapy, 37, 722-728.
-
(1993)
Antimicrobial Agents and Chemotherapy
, vol.37
, pp. 722-728
-
-
Emori, M.1
Saito, H.2
Sato, K.3
Tomioka, H.4
Setogawa, T.5
Hidaka, T.6
-
3
-
-
0028352117
-
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives
-
FUJII, K., TSUJI, A., MIYAZAKI, S., YAMAGUCHI, K., and GOTO, S., 1994, In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. Antimicrobial Agents and Chemotherapy, 38, 1118-1122.
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, pp. 1118-1122
-
-
Fujii, K.1
Tsuji, A.2
Miyazaki, S.3
Yamaguchi, K.4
Goto, S.5
-
4
-
-
0023630956
-
Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimicrobial agents by various methods
-
INDERLIED, C. B., YOUNG, L. S., and YAMAHA, J. K., 1987, Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimicrobial agents by various methods. Antimicrobial Agents and Chemotherapy, 31, 1697-1702.
-
(1987)
Antimicrobial Agents and Chemotherapy
, vol.31
, pp. 1697-1702
-
-
Inderlied, C.B.1
Young, L.S.2
Yamaha, J.K.3
-
5
-
-
0028114141
-
Activity of the benzoxazinorifamycin KRM-1648 and ethambutol against Mycobacterium avium complex in vitro and macrophages
-
INDERLIED, C. B., BARBARA-BURNHAM, L., WU, M., YOUNG, L. S., and BERMUDEZ, L. E., 1994, Activity of the benzoxazinorifamycin KRM-1648 and ethambutol against Mycobacterium avium complex in vitro and macrophages. Antimicrobial Agents and Chemotherapy, 38, 1838-1843.
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, pp. 1838-1843
-
-
Inderlied, C.B.1
Barbara-Burnham, L.2
Wu, M.3
Young, L.S.4
Bermudez, L.E.5
-
6
-
-
0028093427
-
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model
-
KLEMENS, S. P., GROSSI, M. A., and CYNAMON, M. H., 1994, Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, 38, 2245-2248.
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, pp. 2245-2248
-
-
Klemens, S.P.1
Grossi, M.A.2
Cynamon, M.H.3
-
7
-
-
0025977668
-
In vitro activities of new rifamycin derivatives against mycobacteria
-
KUZE, F., YAMAMOTO, T., AMITANI, R., and SUZUKI, K., 1991, In vitro activities of new rifamycin derivatives against mycobacteria. Kekkaku, 66, 7-12.
-
(1991)
Kekkaku
, vol.66
, pp. 7-12
-
-
Kuze, F.1
Yamamoto, T.2
Amitani, R.3
Suzuki, K.4
-
8
-
-
0028835430
-
In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli
-
LUNA-HERRERA, J., REDDY, M. V., and GANGADHARAM, P. R. J., 1995, In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli. Antimicrobial Agents and Chemotherapy, 39, 440-444.
-
(1995)
Antimicrobial Agents and Chemotherapy
, vol.39
, pp. 440-444
-
-
Luna-Herrera, J.1
Reddy, M.V.2
Gangadharam, P.R.J.3
-
9
-
-
0026034493
-
In Vitro antimycobacterial activities of newly synthesized benzoxazinofifamycin
-
SAITO, H., TOMIOKA, H., SATO, K., EMORI, M., YAMANE, T., YAMASHITA, K., HOSOE, K., and HIDAKA, T., 1991, In Vitro antimycobacterial activities of newly synthesized benzoxazinofifamycin. Antimicrobial Agents and Chemotherapy, 35, 542-547.
-
(1991)
Antimicrobial Agents and Chemotherapy
, vol.35
, pp. 542-547
-
-
Saito, H.1
Tomioka, H.2
Sato, K.3
Emori, M.4
Yamane, T.5
Yamashita, K.6
Hosoe, K.7
Hidaka, T.8
-
10
-
-
4243319784
-
Antimicrobial susceptibility tests
-
edited by A. J. Ristuccia and B. A. Cunha (New York: Raven)
-
TILTON, R. C., 1984, Antimicrobial susceptibility tests. In Antimicrobial Therapy, edited by A. J. Ristuccia and B. A. Cunha (New York: Raven), pp. 137-145.
-
(1984)
Antimicrobial Therapy
, pp. 137-145
-
-
Tilton, R.C.1
-
11
-
-
0026515252
-
Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice
-
TOMIOKA, H., SAITO, H., SATO, K., YAMANE, T., YAMASHITA, K., HOSOE, K., FUJII, K., and HIDAKA, T., 1992. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrobial Agents and Chemotherapy, 36, 387-393.
-
(1992)
Antimicrobial Agents and Chemotherapy
, vol.36
, pp. 387-393
-
-
Tomioka, H.1
Saito, H.2
Sato, K.3
Yamane, T.4
Yamashita, K.5
Hosoe, K.6
Fujii, K.7
Hidaka, T.8
-
12
-
-
0027446212
-
In vitro antimicrobial activity benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex determined by the radiometric method
-
TOMIOKA, H., SAITO, H., FUJII, K., SATO, K., and HIDAKA, T., 1993, In vitro antimicrobial activity benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex determined by the radiometric method. Antimicrobial Agents and Chemotherapy, 37, 67-70.
-
(1993)
Antimicrobial Agents and Chemotherapy
, vol.37
, pp. 67-70
-
-
Tomioka, H.1
Saito, H.2
Fujii, K.3
Sato, K.4
Hidaka, T.5
-
13
-
-
0025634037
-
In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex
-
YAMAMOTO, T., AMITANI, R., KUZE, F., and SUZUKI, K., 1990, In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex. Kekkaku, 65, 805-810.
-
(1990)
Kekkaku
, vol.65
, pp. 805-810
-
-
Yamamoto, T.1
Amitani, R.2
Kuze, F.3
Suzuki, K.4
-
14
-
-
0027479998
-
Synthesis and biological activity of 3′-hydroxy-5′-aminobenzoxazinorifamycin derivatives
-
YAMANE, T., HASHIZUME, T., YAMASHITA, K., KONOSHI, K., HOSOE, K., HIDAKA, T., WATANABE, K., KAWAHARADA, H., YAMAMOTO, T., and KUZE, F., 1993, Synthesis and biological activity of 3′-hydroxy-5′-aminobenzoxazinorifamycin derivatives. Chemical and Pharmaceutical Bulletin, 41, 148-155.
-
(1993)
Chemical and Pharmaceutical Bulletin
, vol.41
, pp. 148-155
-
-
Yamane, T.1
Hashizume, T.2
Yamashita, K.3
Konoshi, K.4
Hosoe, K.5
Hidaka, T.6
Watanabe, K.7
Kawaharada, H.8
Yamamoto, T.9
Kuze, F.10
|